Loxo Oncol Drug Patent Portfolio

Loxo Oncol owns 1 orange book drug protected by 4 US patents Given below is the list of Loxo Oncol's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10342780 Compounds useful as kinase inhibitors 16 Dec, 2036
Active
US10464905 Compounds useful as kinase inhibitors 16 Dec, 2036
Active
US10695323 Compounds useful as kinase inhibitors 16 Dec, 2036
Active
US10918622 Compounds useful as kinase inhibitors 16 Dec, 2036
Active


Given below is the list of recent legal activities going on the following drug patents of Loxo Oncol.

Activity Date Patent Number
Patent litigations
Email Notification 14 May, 2024 US10695323
Mail Patent eCofC Notification 14 May, 2024 US10695323
Patent eCofC Notification 14 May, 2024 US10695323
Recordation of Patent eCertificate of Correction 14 May, 2024 US10695323
Second letter to regulating agency to determine regulatory review period 08 May, 2024 US10342780
Post Issue Communication - Certificate of Correction 24 Apr, 2024 US10695323
Mail Certificate of Correction Memo 23 Apr, 2024 US10695323
Certificate of Correction Memo 18 Apr, 2024 US10695323
Letter from FDA or Dept of Agriculture re PTE application 30 Jan, 2024 US10342780
Payment of Maintenance Fee, 4th Year, Large Entity 21 Nov, 2023 US10695323
RX - Mail Miscellaneous Communication to Applicant 03 Aug, 2023 US10918622
Initial letter Re: PTE Application to regulating agency 06 Jul, 2023 US10342780
Payment of Maintenance Fee, 4th Year, Large Entity 20 Apr, 2023 US10464905
Patent Term Extension Application under 35 USC 156 Filed 22 Mar, 2023 US10342780
Post Issue Communication - Certificate of Correction 26 Jan, 2023 US10918622


Loxo Oncol's Family Patents

Loxo Oncol drugs have patent protection in a total of 33 countries. It's US patent count contributes only to 10.3% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Loxo Oncol Drug List

Given below is the complete list of Loxo Oncol's drugs and the patents protecting them.


1. Jaypirca

Jaypirca is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10342780 Compounds useful as kinase inhibitors 16 Dec, 2036
(12 years from now)
Active
US10464905 Compounds useful as kinase inhibitors 16 Dec, 2036
(12 years from now)
Active
US10695323 Compounds useful as kinase inhibitors 16 Dec, 2036
(12 years from now)
Active
US10918622 Compounds useful as kinase inhibitors 16 Dec, 2036
(12 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Jaypirca's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List